News
Scientists are continuing to find evidence that GLP-1 medications can temper cravings for alcohol and other drugs.
Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment ...
Findings showed a 13.6% reduction in body weight in the semaglutide 25mg group compared with a 2.2% reduction in the placebo group.
In a statement sent to Fierce Pharma Marketing, Cristian Azcarate, argenx’s VP of patient strategy, said the company’s work ...
Understand how semaglutide shows strong benefits in MASH treatment, improving liver health and reducing weight.
HealthDay News — For patients with metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis, semaglutide is associated with improved liver histologic outcomes, according to a study ...
Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.
Gray, or gray market medications, are nothing new, and GLP-1s — the class of weight loss wonder drug that includes ...
Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...
The drugmaker is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy ...
Semaglutide and tirzepatide prescriptions within Epic-affiliated health care systems increased slightly between 2021 and 2024, but their uptake remained limited, with only 3% of eligible patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results